Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: A four-year prospective study

Nephrology Dialysis Transplantation

Volumn 30, Issue 3, 2015, Pages 460-466

  Zheng, Tianpeng ^a,b   Baskota, Attit ^a   Gao, Yun ^a   Tian, Haoming ^a   Yang, Fan ^b  

^a SICHUAN UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

ACR; DPP4 activity; inflammation; microalbuminuria

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; ALBUMINURIA; BLOOD; DIABETES MELLITUS; FOLLOW UP; INFLAMMATION; MIDDLE AGED; ODDS RATIO; ONSET AGE; PROGNOSIS;

ADULT; AGE OF ONSET; AGED; ALBUMINURIA; BIOMARKERS; CHINA; DIABETES MELLITUS; DIPEPTIDYL PEPTIDASE 4; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924408372     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu312     Document Type: Article

References (21)

1. Xiao J, Xing X, Lu J et al. Prevalence and associated factors of microalbuminuria in Chinese individuals without diabetes: cross-sectional study. BMJ Open 2013; 3: e003325
2. Sabanayagam C, Lee J, Shankar A et al. C-reactive protein and microalbuminuria in a multi-ethnic Asian population. Nephrol Dial Transplant 2010; 25: 1167-1172
3. Festa A, D'agostino R, Howard G et al. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kid Int 2000; 58: 1703-1710
4. Stuveling EM, Bakker SJ, Hillege HL et al. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004; 43: 791-796
5. Kshirsagar AV, Bomback AS, Bang H et al. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol 2008; 101: 401-406
6. Sun A-l, Deng J-t, Guan G-j et al. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Diab Vasc Dis Res 2012; 9: 301-308
7. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 1999; 85: 9-24
8. Matteucci E, Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 2009; 16: 2943-2951
9. Itou M, Kawaguchi T, Taniguchi E et al. Dipeptidyl peptidase-4: a key player in chronic liver disease.World J Gastroenterol 2013; 19: 2298
10. Zhong J, Rao X, Rajagopalan S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. Atherosclerosis 2013; 226: 305-314
11. Cordero OJ, Salgado FJ, Viñuela JE et al. Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes. Immunobiology 1997; 197: 522-533
12. Ikushima H, Munakata Y, Iwata S et al. Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cell Immunol 2002; 215: 106-110
13. Haluzík M, Frolík J, Rychlík I. Renal effects of DPP-4 inhibitors: a focus on microalbuminuria. Int J Endocrinol 2013; 2013: 895102
14. Lamers D, Famulla S, Wronkowitz N et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011; 60: 1917-1925
15. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101
16. Houlihan CA, Tsalamandris C, Akdeniz A et al. Albumin to creatinine catio: a screening test with limitations. Am J Kid Dis 2002; 39: 1183-1189
17. Luepker R, Evans A, McKeigue P et al. Cardiovascular Survey Methods. Geneva, Switzerland:World Health Organization, 2004
18. Yang F, Zheng T, Gao Y et al. Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China National Diabetes and Metabolic Disorders Study. PLoS One 2014; 9: e92222
19. Nelson KM, Boyko EJ, Koepsell T. All-cause mortality risk among a national sample of individuals with diabetes. Diabetes Care 2010; 33: 2360-2364
20. Bonnet F, Marre M, Halimi JM et al. Larger waist circumference is a predictive factor for the occurrence of microalbuminuria in a non-diabetic population. Arch Mal Coeur Vaiss 2006; 99: 660-662
21. Kirino Y, Sei M, Kawazoe K et al. Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people. Endocr J 2005; 59: 949-953